| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.75B | 39.99B | 38.70B | 35.08B | 31.68B | 28.14B |
| Gross Profit | 23.09B | 23.74B | 22.99B | 21.00B | 18.70B | 16.17B |
| EBITDA | 6.99B | 6.44B | 7.23B | 6.47B | 5.40B | 4.52B |
| Net Income | 4.05B | 4.89B | 4.32B | 3.65B | 3.13B | 2.55B |
Balance Sheet | ||||||
| Total Assets | 50.18B | 57.71B | 49.99B | 50.09B | 43.73B | 40.71B |
| Cash, Cash Equivalents and Short-Term Investments | 9.96B | 10.26B | 10.89B | 9.72B | 9.58B | 9.06B |
| Total Debt | 1.87B | 0.00 | 213.00M | 457.00M | 1.34B | 1.60B |
| Total Liabilities | 7.51B | 9.01B | 7.26B | 8.48B | 8.21B | 7.77B |
| Stockholders Equity | 42.58B | 48.60B | 42.66B | 41.53B | 35.44B | 32.88B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -62.00M | 2.22B | 1.38B | 1.54B | 2.67B |
| Operating Cash Flow | 0.00 | 3.37B | 3.45B | 3.09B | 3.17B | 3.74B |
| Investing Cash Flow | 0.00 | -2.07B | -914.00M | -1.29B | -1.29B | -1.29B |
| Financing Cash Flow | 0.00 | -1.97B | -1.78B | -2.10B | -1.46B | -1.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥6.84B | 12.71 | ― | 2.95% | 7.03% | 5.38% | |
76 Outperform | ¥61.48B | 10.11 | ― | 2.83% | 3.35% | 13.06% | |
71 Outperform | ¥164.03B | 20.62 | ― | 2.73% | 6.29% | -7.19% | |
65 Neutral | ¥7.18B | 9.28 | ― | 1.93% | 10.49% | -10.04% | |
63 Neutral | ¥252.74B | 14.09 | -2.06% | 2.66% | 9.95% | -79.87% | |
60 Neutral | ¥2.86B | 8.44 | ― | 2.21% | 6.47% | 263.24% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |